2016-01-07

Camurus's initial public offering a success

On Thursday December 3, 2015, Camurus started its first day of trading on Nasdaq Stockholm. The share price increased considerably during the first day and Camurus is now the largest company in the biotechnology sector on Nasdaq Stockholm

The price of the Camurus share was set at SEK 57, but at closing time the share was noted at SEK 65,5, an increase of no less than 15,7 percent. The upturn meant that the market capitalization of Camurus was close to SEK 2,5 million at the end of the day. Today (January 2016) the market capitalization is about SEK 2,8 million.

Sandberg Development will remain the largest shareholder in Camurus and will hold appr. 54 percent of the total number of shares in the company.

Latest news

2020-04-03

Camurus announces strong first quarter demand for Buvidal®

Camurus announced today continued strong revenue growth driven by increasing demand for weekly and monthly Buvidal®…

Read more

2020-02-14

Camurus' Full year report 2019

Camurus has published their Full year report 2019

Read more

2019-12-13

Camurus has completed a directed share issue

The directed share issue (which was completed on December 6, 2019) of approximately 3,7 million shares will raise pr…

Read more

2019-12-13

Camurus has now completed a directed share issue

The directed share issue (which was completed on December 6, 2019) of approximately 3,7 million shares will raise pr…

Read more

2019-11-04

GRANULDISK launches PowerGranules BIO

GRANULDISK has launched biodegradable granules, which eliminate the need for pre-washing, all while being kind to th…

Read more